Special Section on Causal Control of Biological Systems with Light

Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures

[+] Author Affiliations
Udi Nussinovitch

Technion-Israel Institute of Technology, Sohnis Family Laboratory for Cardiac Electrophysiology and Regenerative Medicine, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, POB 9649, Haifa 31093, Israel

Rambam Health Care Campus, Department of Internal Medicine A, Haifa 31096, Israel

Lior Gepstein

Technion-Israel Institute of Technology, Sohnis Family Laboratory for Cardiac Electrophysiology and Regenerative Medicine, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, POB 9649, Haifa 31093, Israel

Rambam Health Care Campus, Cardiology Department, Haifa 31096, Israel

Neurophoton. 2(3), 031204 (Jun 23, 2015). doi:10.1117/1.NPh.2.3.031204
History: Received December 27, 2014; Accepted May 19, 2015
Text Size: A A A

Abstract.  Optogenetics has revolutionized neuroscience by enabling precise control of neural excitation. The development of similar optogenetics strategies in the heart is just emerging and mainly focused on pacing with light activation of channelrhodopsin-2. Here, we aimed to develop an optogenetic approach to suppress local cardiac electrical activity by using engineered cell-grafts (HEK293-cells) transfected to express the light-sensitive hyperpolarizing proton-pump archaerhodopsin-3 (Arch3). To evaluate the ability of the engineered cells to couple and modulate the electrical activity of cardiomyocytes, we co-cultured the Arch3-HEK293 cells with neonatal rat cardiomyocytes (NRCMs) or human embryonic stem cells derived cardiomyocytes (hESC-CMs). The co-cultures’ conduction and chronotropic properties were evaluated prior, during, and following application of focused monochromatic light (590 nm) using a multielectrode array mapping system. Application of focused illumination completely silenced electrical activity at the illuminated area in all NRCM co-cultures, leading to development of localized functional conduction blocks. Similarly, illumination significantly slowed spontaneous beating-rate in the hESCs-CMs co-cultures (from 86±9 to 28±4beats/min, p<0.001). Interestingly, a transient acceleration in beating-rate was noted immediately postillumination. In conclusion, a combined gene and cell therapy approach, using light-sensitive hyperpolarizing proteins, could be used to modulate conduction and automaticity in cardiomyocyte cultures, opening the way for future optogenetic treatments for cardiac tachyarrhythmias.

Figures in this Article
© 2015 Society of Photo-Optical Instrumentation Engineers

Topics

Optogenetics

Citation

Udi Nussinovitch and Lior Gepstein
"Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures", Neurophoton. 2(3), 031204 (Jun 23, 2015). ; http://dx.doi.org/10.1117/1.NPh.2.3.031204


Tables

Access This Article
Sign in or Create a personal account to Buy this article ($20 for members, $25 for non-members).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections

PubMed Articles
Advertisement
  • Don't have an account?
  • Subscribe to the SPIE Digital Library
  • Create a FREE account to sign up for Digital Library content alerts and gain access to institutional subscriptions remotely.
Access This Article
Sign in or Create a personal account to Buy this article ($20 for members, $25 for non-members).
Access This Proceeding
Sign in or Create a personal account to Buy this article ($15 for members, $18 for non-members).
Access This Chapter

Access to SPIE eBooks is limited to subscribing institutions and is not available as part of a personal subscription. Print or electronic versions of individual SPIE books may be purchased via SPIE.org.